USPTO Examiner MURPHY VICTORIA - Art Unit 3785

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17247565Apparatus for Delivering a ScentDecember 2020April 2024Abandon4010NoNo
17093710MIXING CHANNEL FOR AN INHALATION DEVICE AND INHALATION DEVICENovember 2020January 2023Allow2600YesNo
17075310RESPIRATORY MASKOctober 2020April 2024Abandon4201NoNo
16998580DEVICES, SYSTEMS, AND METHODS FOR PROTECTING HEALTHCARE WORKERS FROM AIRBORNE PATHOGENSAugust 2020February 2021Allow621YesNo
16917055Patient Ventilator Control Using Constant Flow and Breathing TriggersJune 2020December 2020Allow610YesNo
16882413DEVICES, SYSTEMS, AND METHODS FOR PROTECTING HEALTHCARE WORKERS FROM AIRBORNE PATHOGENSMay 2020February 2021Allow921YesNo
16810096DEVICE AND METHOD FOR AEROSOLIZED DELIVERY OF SUBSTANCE TO A NATURAL ORIFICE OF THE BODYMarch 2020March 2024Abandon4901NoNo
16723257SYSTEM AND ASSEMBLY FOR INFLATING AND MONITORING PRESSURE WITHIN A RETAINING CUFFDecember 2019June 2022Allow3000YesNo
16615278DRY POWDER DELIVERY DEVICE AND METHODS OF USENovember 2019August 2022Allow3210YesNo
16677435CLINICAL DECISION SUPPORT SYSTEM AND METHODSNovember 2019July 2023Allow4410YesNo
16661250SYSTEMS AND METHODS FOR SETUP OF CPAP SYSTEMSOctober 2019December 2021Allow2520YesNo
16607302MEDICINAL INHALER DRIVE MECHANISMOctober 2019February 2021Allow1610YesNo
16496052OPTICAL DRY POWDER INHALER DOSE SENSORSeptember 2019August 2022Abandon3510NoNo
16543858RESPIRATORY THERAPY CONDENSATION ADAPTORAugust 2019October 2022Allow3810YesNo
16521082VAPOR DELIVERY SYSTEM WITH DOSIMETER FOR MEASURING AND COMMUNICATING USER-SETTABLE DOSAGEJuly 2019December 2021Abandon2920YesYes
16520714VAPORIZATION DEVICE DELIVERING METERED AMOUNT OF MEDICANT FROM NON-DOSAGE FORM SOURCEJuly 2019December 2020Abandon1720NoNo
16520028MECHANICAL VENTILATION IN THE PRESENCE OF SLEEP DISORDERED BREATHINGJuly 2019July 2023Allow4800YesNo
16516683VAPORIZER DEVICE HAVING OUTPUT COMPONENT FOR COMMUNICATING AMOUNT OF GENERATED VAPORIZED SUBSTANCEJuly 2019December 2020Abandon1720NoNo
16516643VAPORIZER WITH DOSIMETER INFORMATION COMMUNICATED TO CONNECTED DEVICEJuly 2019December 2020Abandon1720NoNo
16515055INHALER DEVICE, AND METHOD AND PROGRAM FOR OPERATING THE SAMEJuly 2019November 2023Allow5220NoNo
16515860INHALATION DEVICES WITH DOSAGE METERING AND COMPATIBLE WITH STANDARD CONNECTION SYSTEMSJuly 2019November 2021Abandon2821NoNo
16514715VAPORIZER WITH DOSIMETER AND DELIVERED DOSAGE COMMUNICATIONJuly 2019November 2020Abandon1610NoNo
16504667PARTICULATE FILTER FACE MASK HAVING FAN BREATHING ASSISTJuly 2019October 2022Abandon3910NoNo
16436801TRACHEAL TUBE APPARATUS AND METHODSJune 2019April 2022Allow3400YesNo
16430202JET PUMP ADAPTOR FOR VENTILATION SYSTEMJune 2019January 2023Allow4310YesNo
16400197PERSONALIZED FORCED AIR PURIFIERMay 2019July 2023Abandon5120NoNo
16383741SPACER CHAMBER HAVING TWO AEROSOL PORTSApril 2019August 2022Abandon4010NoNo
16382366INHALATION DEVICE WITH CONSTRICTED FLOW PATHWAYApril 2019January 2020Allow901YesNo
16382422DEVICE FOR VAPORIZED SUBSTANCE DOSAGE METERING BASED ON AN INPUT DOSAGEApril 2019June 2021Abandon2621NoNo
16360573ENDOTRACHEAL TUBE FOR MECHANICAL VENTILATIONMarch 2019March 2023Abandon4820NoNo
16260211VAPOR DELIVERY SYSTEM WITH DOSIMETER FOR MEASURING AND COMMUNICATING USER-SETTABLE DOSAGEJanuary 2019June 2022Abandon4110NoNo
16260392Vaporizer device with progressive display of amount of delivered vaporized substanceJanuary 2019August 2022Abandon4310NoNo
16260306VAPORIZATION DEVICE DELIVERING METERED AMOUNT OF MEDICANT FROM NON-DOSAGE FORM SOURCEJanuary 2019June 2022Abandon4110NoNo
16260264VAPORIZATION DEVICE FOR CALCULATING INHALED MEDICANT AMOUNT AND DISPLAYING SAMEJanuary 2019October 2021Abandon3310NoNo
16318482DEVICE AND METHODS COMPRISING A FLUIDIC DIVERTER FOR ASSISTING BREATHINGJanuary 2019June 2023Abandon5330NoNo
16249389DEVICE FOR VAPORIZED SUBSTANCE DOSAGE METERING BASED ON AN INPUT DOSAGEJanuary 2019October 2021Abandon3301NoNo
16249477INHALATION DEVICE WITH CONSTRICTED FLOW PATHWAYJanuary 2019July 2020Abandon1801NoNo
16316992RESPIRATION-CONTROLLED APPLICATION OF AEROSOL IN POWDER FORM DURING THE ARTIFICIAL RESPIRATION OR SUPPORTED RESPIRATION OF A PATIENTJanuary 2019December 2022Allow4711YesNo
16242260METHODS AND SYSTEMS FOR LEAK ESTIMATIONJanuary 2019September 2021Allow3310YesNo
16238883FOREHEAD SUPPORTS FOR FACIAL MASKJanuary 2019March 2021Allow2700YesNo
16230119ARRANGEMENT IN THE FORM OF A TRACHEOSTOMA PROSTHESIS FOR EASY INSERTION AND EASY REMOVAL OF AN INNER CANNULADecember 2018October 2020Allow2100YesNo
16230754INHALATION DEVICE WITH METERINGDecember 2018July 2020Abandon1810NoNo
16230495INHALATION DEVICE WITH METERINGDecember 2018April 2021Abandon2810NoNo
16230640VAPORIZER WITH DOSIMETER INFORMATION COMMUNICATED TO CONNECTED DEVICEDecember 2018March 2021Abandon2710NoNo
16310624STEAM HEATING TOOL AND METHOD OF USING THE SAMEDecember 2018November 2022Abandon4740NoNo
16221443System and Method for the Pulsed Release of Oxygen for Personal UseDecember 2018February 2024Abandon6031NoNo
16309739NICOTINE INHALER SYSTEMDecember 2018November 2021Allow3511YesNo
16218220SYSTEM FOR PROVIDING OXYGEN TO OXYGEN MASKS IN AN AIRCRAFTDecember 2018May 2022Allow4101YesNo
16213770BILEVEL RESPIRATORY THERAPY SYSTEM, CONTROLLER AND METHODDecember 2018March 2023Abandon5120NoNo
16308118METHOD FOR INHALATION EFFECT ON THE BODY, AND APPARATUS FOR IMPLEMENTING SAMEDecember 2018October 2022Abandon4620NoNo
16207049INHALANT DELIVERY APPARATUS, SYSTEM AND METHODNovember 2018April 2021Allow2920YesNo
16203447WATER-BASED VAPORIZABLE LIQUIDS, METHODS AND SYSTEMS FOR VAPORIZING SAMENovember 2018June 2022Abandon4310NoNo
16198403INTRANASAL DEVICE WITH DIP TUBENovember 2018November 2022Allow4820YesNo
16196233ON-DEMAND OXYGEN DISPENSING SYSTEM FOR AIRCRAFT PASSENGERSNovember 2018March 2022Abandon4001NoNo
16098640AIR PURIFIER APPARATUS WITH FLEXIBLE FILTER MODULESNovember 2018February 2022Allow4040YesNo
16172193METHOD AND DEVICE FOR VAPORIZING PHYTO MATERIALOctober 2018October 2022Allow4801YesNo
16093886SYSTEMS, DEVICES AND METHODS FOR ASSESSING INHALATION THERAPYOctober 2018September 2021Allow3520YesNo
16158871DEVICE FOR MEDICAL BREATHING TREATMENTOctober 2018June 2022Allow4420YesNo
16093344Headgear for First RespondersOctober 2018November 2022Abandon4940YesNo
16092488METHOD OF CONTROLLING A POWERED AIR PURIFYING RESPIRATOROctober 2018November 2021Allow3720NoNo
16153876NASAL DELIVERYOctober 2018February 2024Abandon6070YesNo
16149981ADAPTER FOR DRUG DELIVERYOctober 2018November 2021Abandon3720NoNo
16149471INHALATION DEVICE FOR GENERATING AEROSOL AND METHOD FOR GENERATING AEROSOLOctober 2018August 2021Abandon3501NoNo
16090296MEDICINAL INHALER REFILL ASSEMBLIES COMPRISING A LOCKOUT OVERRIDE MECHANISMOctober 2018January 2022Allow4020NoNo
16088100Multiple Chamber Respirator Sealing Devices And MethodsSeptember 2018February 2021Allow2810NoNo
16088388DELIVERY SYSTEMS AND METHODS FOR ELECTRIC PLASMA SYNTHESIS OF NITRIC OXIDESeptember 2018December 2022Allow5051YesNo
16137852Intranasal Delivery DevicesSeptember 2018January 2023Allow5210YesNo
16120888BREATHING TUBESeptember 2018November 2020Allow2610YesNo
16108839Methods and Apparatus for Preventing RainoutAugust 2018November 2021Allow3820YesNo
16014123DIVING SYSTEMJune 2018October 2020Abandon2810NoNo
16064649Facemask with Nonmetallic Nose Member and Method of Manufacturing SameJune 2018June 2021Abandon3620NoNo
16014310PARTITION PLATE DEVICE OF A RESPIRATOR MASKJune 2018July 2020Allow2530YesNo
16064173NICOTINE POWDER DELIVERY SYSTEMJune 2018January 2022Allow4330YesNo
16064421FLOW GOVERNOR ASSEMBLIES FOR USE IN MEDICINAL INHALERSJune 2018March 2022Allow4421YesNo
16064367FLOW GOVERNORS FOR USE IN MEDICINAL INHALERSJune 2018March 2022Allow4530YesNo
16064413AUTO-RESET DOSE RELEASE FIRING SYSTEMS, MEDICINAL INHALERS COMPRISING SAME, AND METHODS OF USING SAMEJune 2018March 2021Allow3311NoNo
16063454WATER REMOVAL SYSTEM FOR AN OXYGEN CONCENTRATOR SYSTEMJune 2018December 2022Abandon5440NoNo
15990924INHALATION DEVICE WITH CONSUMPTION METERING INCLUDING ONE OR MORE AIRFLOW SENSORSMay 2018July 2020Abandon2520NoNo
15975301Hypoxia Training DeviceMay 2018March 2021Allow3411NoNo
15736846CONTROL DEVICE FOR A MEDICAL AEROSOL DELIVERY DEVICEDecember 2017November 2021Allow4720YesYes
15559417PROTECTIVE MASKSeptember 2017March 2020Abandon2910NoNo
15558216TRACHEOSTOMY TUBE ASSEMBLIESSeptember 2017March 2020Abandon3010NoNo
15704020Tracheal Tube CoverSeptember 2017July 2020Abandon3450YesNo
15703574INHALER AND MESH FOR AN INHALERSeptember 2017July 2023Abandon6090NoNo
15731814Medical cannabis and cannabinoids delivery deviceAugust 2017July 2020Abandon3520YesNo
15669348HARNESS DESIGN FOR RESPIRATORY SYSTEMAugust 2017July 2020Allow3511YesNo
15669066INHALER WITH ONE OR MORE VISUAL SENSORSAugust 2017June 2021Abandon4620NoNo
15668681COMBINATION ANESTHESIA CIRCUIT HOLDER AND PATIENT PROTECTION DEVICE AND METHOD OF USEAugust 2017July 2020Allow3511YesNo
15666892ORAL AIRWAY SECURING SYSTEMS AND METHODSAugust 2017August 2020Abandon3611YesNo
15667061MEDICAL NEBULIZER WITH IMPROVED STRUCTUREAugust 2017October 2021Abandon5131NoNo
15653840FILTER AND ITS MANUFACTURING PROCESSJuly 2017July 2023Abandon6060YesNo
15525345DEVICE FOR DISTRIBUTION OF FLUID PRODUCT TRIGGERED BY INHALATIONMay 2017March 2021Allow4620NoNo
15524340MULTIFUNCTONAL APPLICATOR WHICH CAN BE USED IN A MOBILE MANNER FOR MOBILE USEMay 2017October 2021Allow5330YesNo
15585999APPARATUS TO ATTAIN AND MAINTAIN TARGET END TIDAL PARTIAL PRESSURE OF A GASMay 2017October 2019Allow2930YesNo
15585494RESPIRATOR MADE FROM IN-SITU AIR-LAID WEB(S)May 2017December 2020Abandon4310NoNo
15482441METHOD FOR DETERMINING GASES PROPORTIONS IN AN INHALABLE MEDICAL GASEOUS COMPOSITION AND INHALATION TEMPERATURE OF SUCH INHALABLE MEDICAL GASEOUS COMPOSITIONApril 2017September 2021Abandon5321NoNo
15473757MASK SYSTEMMarch 2017November 2020Abandon4301NoNo
15328978REVERSIBLE AIRWAY DEVICE AND RELATED METHOD FOR VENTILATING A SUBJECTJanuary 2017December 2019Allow3530YesYes
15369522NEBULIZER APPARATUSDecember 2016January 2020Allow3830YesNo
15298712VAPOR TRANSFER CARTRIDGEOctober 2016November 2021Allow6021YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MURPHY, VICTORIA.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
7
Examiner Affirmed
4
(57.1%)
Examiner Reversed
3
(42.9%)
Reversal Percentile
66.2%
Higher than average

What This Means

With a 42.9% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
15
Allowed After Appeal Filing
4
(26.7%)
Not Allowed After Appeal Filing
11
(73.3%)
Filing Benefit Percentile
40.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 26.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner MURPHY, VICTORIA - Prosecution Strategy Guide

Executive Summary

Examiner MURPHY, VICTORIA works in Art Unit 3785 and has examined 164 patent applications in our dataset. With an allowance rate of 59.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 48 months.

Allowance Patterns

Examiner MURPHY, VICTORIA's allowance rate of 59.1% places them in the 20% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by MURPHY, VICTORIA receive 2.77 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by MURPHY, VICTORIA is 48 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +64.6% benefit to allowance rate for applications examined by MURPHY, VICTORIA. This interview benefit is in the 97% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 20.6% of applications are subsequently allowed. This success rate is in the 26% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 19.2% of cases where such amendments are filed. This entry rate is in the 25% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 78% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 61.1% of appeals filed. This is in the 39% percentile among all examiners. Of these withdrawals, 18.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 40.0% are granted (fully or in part). This grant rate is in the 29% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 52% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.